Page 9385
Oct 18, 2018
Doctors Can Finally 3D Print Human Tissue, Ligaments and Tendons
Posted by Marcos Than Esponda in categories: 3D printing, biotech/medical
Biomedical engineers have successfully 3D printed human ligaments and tendons, giving hope to patients suffering from tears and ruptures.
After two years of intensive research, biomedical engineers have successfully 3D printed the complex structures of human ligaments and tendons.
Continue reading “Doctors Can Finally 3D Print Human Tissue, Ligaments and Tendons” »
Oct 18, 2018
First proof of quantum computer advantage
Posted by Genevieve Klien in categories: computing, quantum physics
For many years, quantum computers were not much more than an idea. Today, companies, governments and intelligence agencies are investing in the development of quantum technology. Robert König, professor for the theory of complex quantum systems at the TUM, in collaboration with David Gosset from the Institute for Quantum Computing at the University of Waterloo and Sergey Bravyi from IBM, has now placed a cornerstone in this promising field.
This video is the second in a multi-part series discussing computing. In this video, we’ll be discussing computing – more specifically, Moore’s Law with the exponential growth of technology due to our ability to pack more and more transistors into integrated circuits and the potential death of Moore’s Law!
[0:30–3:50] Starting off we’ll look at, how the integrated circuit has shaped the world due to our ability to pack more and more transistors into them, more specifically, in their usage in computing in the form of microprocessors (CPUs) and other computation related hardware.
[3:50–7:11] Following that we’ll discuss, how the transistor will continue to shrink onwards from this year, 2017 and the latest innovations that can shrink them even further, such as FinFETs.
Oct 18, 2018
Dr. James Peyer – A Portfolio Approach To Longevity
Posted by Steve Hill in categories: biotech/medical, life extension
Earlier this year, we hosted the Ending Age-Related Diseases 2018 conference at the Cooper Union in New York City. This conference was designed to bring together the best in the aging research and biotech investment worlds and saw a range of industry experts sharing their insights.
Dr. James Peyer is the founder and Managing Partner of Apollo Ventures, an early-stage life science investor and company builder that focuses on breakthrough technologies for treating age-related diseases.
Continue reading “Dr. James Peyer – A Portfolio Approach To Longevity” »
Oct 18, 2018
Cosmologist Martin Rees gives humanity a 50–50 chance of surviving the 21st century
Posted by Xavier Rosseel in category: futurism
‘’In the medieval period, life was miserable and there wasn’t anything people could do to improve it. Today, the gap between the way the world is and the way it could be is enormous.
But he’s still an optimist.
Oct 18, 2018
Elon Musk says ‘Teslaquila’ is ‘coming soon’ as Tesla files trademark
Posted by Shailesh Prasad in categories: Elon Musk, sustainability, transportation
Billionaire tweets ‘visual approximation’ of bottle as company applies to use the name for tequila branded after the electric cars.
Oct 18, 2018
The data revolution: privacy, politics and predictive policing | The Economist
Posted by Derick Lee in category: engineering
Ms. Powell does not have any easy or obvious ideas for how to address tech’s monoculture. She thinks of her book as starting a conversation. But any solution, she said, will involve “a fundamental, bottoms-up cultural change” — and one that we should not expect to see overnight.
In a satirical new novel, a former Google executive identifies the technology industry’s chief issue: its narrow engineering-focused bubble.
Oct 18, 2018
American tech giants are making life tough for startups
Posted by Derick Lee in category: futurism
The behemoths’ annual conferences, held to announce new tools, features, and acquisitions, always “send shock waves of fear through entrepreneurs”, says Mike Driscoll, a partner at Data Collective, an investment firm. “Venture capitalists attend to see which of their companies are going to get killed next.” But anxiety about the tech giants on the part of startups and their investors goes much deeper than such events. Venture capitalists, such as Albert Wenger of Union Square Ventures, who was an early investor in Twitter, now talk of a “kill-zone” around the giants. Once a young firm enters, it can be extremely difficult to survive. Tech giants try to squash startups by copying them, or they pay to scoop them up early to eliminate a threat.
Big, rich and paranoid, they have reams of data to help them spot and buy young firms that might challenge them.
Continue reading “American tech giants are making life tough for startups” »